等待開盤 03-26 09:30:00 美东时间
-0.080
-0.20%
今日重点评级关注:Guggenheim:维持Cabaletta Bio"买入"评级,目标价从15美元升至16美元;HC Wainwright & Co.:维持Palvella Therapeutics"买入"评级,目标价从255美元升至270美元
03-25 10:31
Truist Securities analyst Gabe Daoud initiates coverage on CNX Resources (NYSE:CNX) with a Sell rating and announces Price Target of $35.
03-24 22:15
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:17
美国天然气期货上涨3.3%,至每百万英热单位3.166美元,有望创下3月12日以来最高收盘水平。 由于伊朗导弹袭击卡塔尔液化天然气设施以及中东其他能源基...
03-19 22:55
BUZZ-US natgas companies rise after Iranian missile hits Qatar LNG site ** Shares of U.S. natural gas companies up, tracking a rise in natgas futures NGA/ ** U.S. natural gas futures NGc1 up 3.3% at $3.166 per million British thermal units (mmBtu), putting the contract on track for its highest close
03-19 22:34
特朗普放话!对伊军事行动本周不结束,油价涨超3%;高盛预警!若油价持续走高,标普500恐暴跌近20%;Nebius盘前急挫超5%,拟私募发行37.5亿美元可转换优先票据>>
03-17 20:14
今日重点评级关注:HC Wainwright & Co.:维持Altimmune"买入"评级,目标价从12美元升至25美元;BTIG:维持Jade Biosciences"买入"评级,目标价从28美元升至39美元
03-17 11:45
Barclays analyst Betty Jiang maintains CNX Resources (NYSE:CNX) with a Underweight and raises the price target from $35 to $36.
03-16 22:49
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics March 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Alnylam Pharmaceuticals, Cogent Biosciences and Summit Therapeutics on Monday
03-16 18:00
In a report released on March 13, Betty Jiang from Barclays maintained a Sell r...
03-16 09:27